We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · July 15, 2020

Effect of CRP on Lp(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease

JAMA Cardiology

 

Additional Info

JAMA Cardiology
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial
JAMA Cardiol 2020 Jul 08;[EPub Ahead of Print], R Puri, SE Nissen, BJ Arsenault, J St John, JS Riesmeyer, G Ruotolo, E McErlean, V Menon, L Cho, K Wolski, AM Lincoff, SJ Nicholls

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading